SCHEMBL3660874

SCHEMBL3660874

CC(C)(C)OC(=O)N1CCCC(Cn2ccc(Br)cc2=O)C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 1/20 0.48
FPR2 P25090 2/20 0.44
FPR3 P25089 1/20 0.44
USP30 Q70CQ3 3/20 0.44
BACE1 P56817 2/20 0.44
ACKR3 P25106 1/20 0.44
CTSD P07339 1/20 0.44
BCHE P06276 2/20 0.44
HTR6 P50406 2/20 0.44
CYP2C9 P11712 1/20 0.42
KDM1A O60341 1/20 0.42
SCN9A Q15858 1/20 0.42
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
KMT2A Q03164 1/20 0.41
GLS O94925 1/20 0.41
KAT7 O95251 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31108111 0.94 IDO1 (0.46) FEN1FPR2FPR3USP30IDO1
SCHEMBL31108119 0.89 USP30 (0.43) FPR2FPR3USP30IDO1TDO2
SCHEMBL31108104 0.87 FPR2 (0.51) FPR2FPR3BACE1MAPT
SCHEMBL27858932 0.81 CNR1 (0.32) FEN1USP30MEN1ALDH1A1KMT2A
SCHEMBL4488171 0.81 HTR6 (0.50) FEN1USP30ACKR3BCHEHTR6
SCHEMBL3664921 0.81 USP30 (0.46) FEN1FPR2FPR3USP30BACE1
SCHEMBL30775975 0.80 ROCK2 (0.38) FPR2USP30BACE1
SCHEMBL4466043 0.76 HTR6 (0.51) FEN1USP30ACKR3BCHEHTR6
SCHEMBL376819 0.75 MEN1 (0.54) FEN1FPR2FPR3BACE1ACKR3
SCHEMBL1974493 0.75 MEN1 (0.54) FEN1FPR2FPR3BACE1ACKR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231653-B1 ANTIBACTERIAL CONDENSED THIAZOLES BIOTA EUROPE LTD (GB) 2013-04-03 EP disclosed
US-8299065-B2 Antibacterial condensed thiazoles BIOTA EUROPE LTD. (GB) 2012-10-30 US disclosed
US-20100305067-A1 ANTIBACTERIAL CONDENSED THIAZOLES BIOTA EUROPE LTD (GB) 2010-12-02 US disclosed
EP-2231653-A1 ANTIBACTERIAL CONDENSED THIAZOLES Biota Europe Ltd (GB) 2010-09-29 EP disclosed
WO-2009074812-A1 ANTIBACTERIAL CONDENSED THIAZOLES PROLYSIS LTD (GB) 2009-06-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305067-A1 ANTIBACTERIAL CONDENSED THIAZOLES NEK6, NEK1, TXK FEN1 2096/4885FPR2 925/4885FPR3 617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.